Literature DB >> 16632163

Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting.

Chi-Un Pae1.   

Abstract

The antagonism of 5-HT3 receptor by mirtazapine results in an antiemetic effect, suggesting that mirtazapine could be considered a successful antiemetic agent in patients suffering from severe nausea and vomiting. There have been several reports of successful mirtazapine treatment for nausea or vomiting from secondary causes but cases of primary severe nausea and vomiting are still lacking, in particular, there are no reported cases in Asians. The authors report two cases with severe nausea and vomiting that were dramatically treated with mirtazapine in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632163     DOI: 10.1016/j.pnpbp.2006.03.015

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  9 in total

1.  Mirtazapine: a solution for postoperative gastroparesis?

Authors:  Marianne Johnstone; Pranai Buddhdev; Michael Peter; Robert Diggory
Journal:  BMJ Case Rep       Date:  2009-08-17

Review 2.  Newest Drugs for Chronic Unexplained Nausea and Vomiting.

Authors:  William L Hasler
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

Review 3.  The pharmacologic management of insomnia in patients with HIV.

Authors:  Toma S Omonuwa; Harold W Goforth; Xavier Preud'homme; Andrew D Krystal
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

Review 4.  [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].

Authors:  G Benze; B Alt-Epping; A Geyer; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

5.  An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients.

Authors:  Mehmet A Ersoy; Aysin M Noyan; Hayriye Elbi
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 6.  Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines.

Authors:  L Lee Dupuis; Paul C Nathan
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

7.  Psychiatric Co-morbidity and Efficacy of Mirtazapine Treatment in Young Subjects With Chronic or Cyclic Vomiting Syndromes: A Case Series.

Authors:  Murat Coskun; Behiye Alyanak
Journal:  J Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 4.924

8.  Effect of Mirtazapine on Gastric Emptying in Patients with Cancer-associated Anorexia.

Authors:  N Kumar; Sukanta Barai; S Gambhir; N Rastogi
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep

9.  Mirtazapine for symptom control in refractory gastroparesis.

Authors:  Mark Malamood; Aaron Roberts; Rahul Kataria; Henry P Parkman; Ron Schey
Journal:  Drug Des Devel Ther       Date:  2017-03-30       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.